Generic Name and Formulations:
Japanese encephalitis virus vaccine; inactivated; aluminum hydroxide adsorbed; susp for IM inj; contains formaldehyde, protamine sulfate; preservative-free.
Indications for IXIARO:
Japanese encephalitis virus (JEV) immunization in patients ≥2mos of age.
Adults and Children:
<2mos: not established. Give only by IM inj into anterolateral aspect of the thigh (2mos–<3yrs) or the deltoid muscle (≥3yrs; for 1–<3yrs if muscle mass adequate). Primary series: give doses 28 days apart; complete series at least 1 week before potential exposure. 2mos–<3yrs: two 0.25mL doses; ≥3yrs: two 0.5mL doses. Booster dose (3rd dose): may give at least 11mos after completing the primary series if JEV risks remain. 14mos–<3yrs: one 0.25mL dose; ≥3yrs: one 0.5mL dose.
Severe allergic reaction (eg, anaphylaxis) after a previous dose.
Immunocompromised. Allergy to protamine sulfate. Have appropriate medical treatment readily available. Pregnancy. Nursing mothers.
Japanese encephalitis vaccine.
Avoid concomitant injectable vaccines in the same syringe or injection site; see full labeling. Immunosuppressants may diminish immune response.
Inj site reactions (eg, redness, pain, tenderness), fever, irritability, diarrhea, headache; hypersensitivity reactions, syncope.
Single-dose syringe (0.5mL)—1
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Nomophobia: The Modern-Day Pathology
- Emerging Theories in the Pathophysiology of MDD: Could the Opioid System Be Involved?
- Transdermal Nicotine Boosts Mood and Cognitive Function in Late-Life Depression
- Combination Cognitive Behavioral Therapy With Fluoxetine Effective for Adolescent Depression
- Prazosin May Be Effective as Treatment for Alcohol Use Disorder
- Text Message Reminders Improve Medication Adherence in Bipolar I Disorder
- Improving Medication Adherence in ADHD Lowers Risk for Oppositional Defiant Disorder, Conduct Disorder in Adulthood
- High Suicidality Among Children With ADHD Mediated by Family Functioning, Psychiatry Comorbidities
- Pilot Study Investigates Lithium vs Quetiapine for Bipolar Spectrum Disorder
- How Personalized Hospital Ratings May Drive Patient-Specific Care in the Digital Age